LEXINGTON, Mass.--(BUSINESS WIRE)--Critical Therapeutics, Inc. (Nasdaq: CRTX) has granted an exclusive worldwide license to Innovative Metabolics, Inc. for intellectual property rights related to the development and commercialization of medical device approaches to stimulating the vagus nerve, which is believed to play a role in regulating the body’s inflammatory response.
